CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of ...

CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus infectionsCompany to present Phase 1 data and updates from ongoing Phase 1b study conducted ...

Once norovirus is circulating, it can quickly become an outbreak.

To date, there are no approved vaccines or antiviral treatments for human norovirus, the leading cause of acute gastroenteritis outbreaks worldwide with more than 685 million infections each year.

Cocrystal Pharma, Inc. announced that its investigational antiviral drug CDI-988 has shown strong efficacy against the newly dominant norovirus variants GII.17 and previously prevalent GII.4, amid a ...

The highly contagious norovirus – popularly known as "stomach flu" or the "winter vomiting bug" – is now surging through the U.S. The number of outbreaks is up significantly over previous years, ...

Norovirus is ripping across Northern California as dozens are falling sick with horrific symptoms. The “extremely contagious” virus is sweeping over western San Francisco, Marin, Novato, Palo Alto, ...

Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...

Add Yahoo as a preferred source to see more of our stories on Google. Kinga Krzeminska/Getty Images Norovirus outbreaks are popping up around the United States, causing concern during a winter when ...

Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...

We might be near the end of winter, but the spread of norovirus shows little sign of slowing down. The number of people in hospital with the winter vomiting bug has hit a record h ...

Stopping viruses before they strike is a key challenge in public health. A research team led by Associate Professor Li Dan ...